Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

289 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Life prognosis and renal relapse after induction therapy in Japanese patients with proliferative and pure membranous lupus nephritis.
Okamoto M, Kitamura M, Sato S, Fujikawa K, Horai Y, Matsuoka N, Tsuboi M, Nonaka F, Shimizu T, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A, Ichinose K. Okamoto M, et al. Among authors: origuchi t. Rheumatology (Oxford). 2021 May 14;60(5):2333-2341. doi: 10.1093/rheumatology/keaa599. Rheumatology (Oxford). 2021. PMID: 33166998
Inhibitory effect of a new anti-rheumatic drug T-614 on costimulatory molecule expression, cytokine production, and antigen presentation by synovial cells.
Kawakami A, Tsuboi M, Urayama S, Matsuoka N, Yamasaki S, Hida A, Aoyagi T, Furuichi I, Nakashima T, Migita K, Kawabe Y, Nakashima M, Origuchi T, Eguchi K. Kawakami A, et al. Among authors: origuchi t. J Lab Clin Med. 1999 Jun;133(6):566-74. doi: 10.1016/s0022-2143(99)90186-5. J Lab Clin Med. 1999. PMID: 10360631
Clinical outcome and survival of secondary (AA) amyloidosis.
Tanaka F, Migita K, Honda S, Fukuda T, Mine M, Nakamura T, Yamasaki S, Ida H, Kawakami A, Origuchi T, Eguchi K. Tanaka F, et al. Among authors: origuchi t. Clin Exp Rheumatol. 2003 May-Jun;21(3):343-6. Clin Exp Rheumatol. 2003. PMID: 12846054
Protection of mitochondrial perturbation by human T-lymphotropic virus type 1 tax through induction of Bcl-xL expression.
Nakashima K, Kawakami A, Hida A, Yamasaki S, Nakamura H, Kamachi M, Miyashita T, Tanaka F, Izumi Y, Tamai M, Ida H, Furuyama M, Koji T, Nakamura T, Migita K, Origuchi T, Eguchi K. Nakashima K, et al. Among authors: origuchi t. J Lab Clin Med. 2003 Nov;142(5):341-7. doi: 10.1016/S0022-2143(03)00134-3. J Lab Clin Med. 2003. PMID: 14647038
Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells.
Miyashita T, Kawakami A, Nakashima T, Yamasaki S, Tamai M, Tanaka F, Kamachi M, Ida H, Migita K, Origuchi T, Nakao K, Eguchi K. Miyashita T, et al. Among authors: origuchi t. Clin Exp Immunol. 2004 Aug;137(2):430-6. doi: 10.1111/j.1365-2249.2004.02534.x. Clin Exp Immunol. 2004. PMID: 15270863 Free PMC article.
A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
Ida H, Kawasaki E, Miyashita T, Tanaka F, Kamachi M, Izumi Y, Huang M, Tamai M, Origuchi T, Kawakami A, Migita K, Motomura M, Yoshimura T, Eguchi K. Ida H, et al. Among authors: origuchi t. Rheumatology (Oxford). 2004 Oct;43(10):1292-9. doi: 10.1093/rheumatology/keh320. Epub 2004 Jul 27. Rheumatology (Oxford). 2004. PMID: 15280569
289 results